Skip to Content

Veeva Systems Inc Class A VEEV

Morningstar Rating
$198.38 −1.16 (0.58%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Veeva: Leadership Transition Doesn’t Alter Our Favorable Long-Term Outlook

Veeva announced on April 1 that Brent Bowman—the firm’s chief financial officer and principal financial officer, who has been serving in the position for over three years—will step down. The announcement noted that the departure was not a result of any misconduct or disagreements between Bowman and Veeva. During the search for a replacement, Tim Cabral, Veeva’s CFO from 2010 to 2020, will serve as interim CFO and PFO with Bowman remaining as an advisor to ensure a smooth transition. We believe Cabral will be an effective member during this changeover given he brings in decades of experience and knowledge, and has also served as a board member since January 2022.

Price vs Fair Value

VEEV is trading at a 26% discount.
Price
$199.54
Fair Value
$487.00
Uncertainty
High
1-Star Price
$686.40
5-Star Price
$876.00
Economic Moat
Jry
Capital Allocation
Flqjgqjy

Bulls Say, Bears Say

Bulls

Veeva Vault continues to implement new products to its suite, which makes the offering even more attractive.

Bears

Moving its CRM from Salesforce’s platform to its Vault Platform could raise concerns for customers and lower its retention rate.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VEEV is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$199.54
Day Range
$197.03199.65
52-Week Range
$160.21236.90
Bid/Ask
$198.02 / $198.38
Market Cap
$32.00 Bil
Volume/Avg
735,422 / 1.0 Mil

Key Statistics

Price/Earnings (Normalized)
41.23
Price/Sales
13.80
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company’s best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Mid Growth
Total Number of Employees
7,172

Competitors

Valuation

Metric
VEEV
CRM
ORCL
Price/Earnings (Normalized)
41.2333.0020.68
Price/Book Value
6.934.4356.67
Price/Sales
13.807.686.21
Price/Cash Flow
38.3620.4517.32
Price/Earnings
VEEV
CRM
ORCL

Financial Strength

Metric
VEEV
CRM
ORCL
Quick Ratio
4.170.960.69
Current Ratio
4.241.090.85
Interest Coverage
18.873.95
Quick Ratio
VEEV
CRM
ORCL

Profitability

Metric
VEEV
CRM
ORCL
Return on Assets (Normalized)
15.10%8.50%11.69%
Return on Equity (Normalized)
18.98%13.87%749.60%
Return on Invested Capital (Normalized)
15.89%11.66%20.33%
Return on Assets
VEEV
CRM
ORCL
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GEHC
GE HealthCare Technologies Inc Common StockBvwschg$38.8 Bil
SOLV
Solventum CorpDpslll$10.7 Bil
MTHRF
M3 IncDnsbd$8.3 Bil
MTHRY
M3 Inc ADRDvzjkc$8.3 Bil
HQY
HealthEquity IncRtpfxh$6.9 Bil
PMCUF
Pro Medicus LtdSntvhq$6.9 Bil
RCM
R1 RCM IncRytms$5.1 Bil
DOCS
Doximity Inc Class AGqlmbk$4.6 Bil
TXG
10x Genomics Inc Ordinary Shares - Class AYmkt$3.4 Bil

Sponsor Center